Infinium Global Research Cancer Vaccines Market

Cancer Vaccines Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 Executive Summary Global Cancer vaccineMarket Highlights, (USD Million) The global cancer vaccinemarket is expected to grow at a CAGR of 17.8% between 2017 and 2023 in terms of value. Globally, the cancer vaccinemarket is expected to be driven by factors such as increase in occurrence & prevalence of cancer, technological advancements in treatment therapies, growth in number of R&D for the treatment of cancer, and specificity & efficiency of cancer vaccine for the treatment of wide range of cancers such as Whole Cell Cancer Vaccine, Antigen/Adjuvant Cancer Vaccines, Dendritic Cells Cancer Vaccines, and others.The increasing number of clinical trials held particularly in vaccine is expected to boost the market’s growth.There are two types of cancer prevention vaccines approved by the U.S. Food and Drug Administration (FDA) they are HPV vaccine and Hepatitis B vaccine.Moreover, factors such as high abrasion rates during product development phase, lack of awareness about vaccine and high cost of clinical trials are anticipated to restrict the growth of the market. North America is the largest commercial refrigeration market, followed by Asia–Pacific and Europe. Asia-Pacific region is anticipated to become the fastest growing cancer inmmunotherapy market in terms of CAGR during the forecast period. The increase in number of patient, rise in occurrence of different types of cancer, and increase in government investments for R&D and the healthcare reforms for the treatment of cancer.The key player of global cancer vaccines market include, Glaxosmithkline Plc, Aduro BioTech Inc., Astellas Pharma Inc., Merck & Co., Inc., CSL Limited, Sanpower Group, Sanofi Pasteur, Pfizer Inc, Serum Institute of India Pvt. Ltd., and Others. For More Details Get Free Sample Pages of this Premium Report: - https://www.infiniumglobalresearch.com/reports/sample-request/1096 © Infinium Global Research Page 7

Infinium Global Research Cancer Vaccines Market | Page 7